- You can view the full Charming Shoppes Ratings Report.
- Use our retail section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Besides Sanofi, Biogen is the next most likely to complete a sizable transaction in the next 12 months, according to Credit Suisse analysts.
Trade-Ideas LLC identified Coherus BioSciences (CHRS) as a weak on high relative volume candidate